Anti-streptokinase antibodies inhibit fibrinolytic effects of anistreplase in acute myocardial infarction

This publication has 15 references indexed in Scilit:

• Streptokinase Resistance Test in Patients with Streptococcal Infection and/or High Antistreptolysin Titers
  Scandinavian Journal of Haematology, 2009
• A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.
  Heart, 1990
• Antistreptokinase titres after intravenous streptokinase
  The Lancet, 1990
• Thrombolytic Therapy: Current Status
  New England Journal of Medicine, 1988
• Usefulness of residual plasma fibrinogen after intravenous streptokinase for predicting delay or failure of reperfusion in acute myocardial infarction
  The American Journal of Cardiology, 1986
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.
  Circulation, 1985
• Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibody
  Journal of the American College of Cardiology, 1984
• THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. I. INDUCTION AND EFFECTS*
  Journal of Clinical Investigation, 1959
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
  Acta Haematologica, 1957